NDC 70168-8300

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 70168-8300
Product root: 70168-8300
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	70168-8300	70168-8300-1	COMPOUNDER	Outsourcing facility compounded drug report	2025-2	2026-08-03
compounder	package	70168-8300	70168-8300-1	COMPOUNDER	Outsourcing facility compounded drug report	2025-1	2025-09-25
compounder	package	70168-8300	70168-8300-1	COMPOUNDER	Outsourcing facility compounded drug report	2025-1	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 2 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-12-16 00:49 UTC · source 2025-09-25	compounder	package	70168-8300	70168-8300-1	COMPOUNDER	Outsourcing facility compounded drug report	2025-1	compounder / compounders_ndc_directory.zip	`3f6f48d8db7b…`	`6316a3eebc6a…`
2025-08-27 00:00 UTC · source 2025-08-20	compounder	package	70168-8300	70168-8300-1	COMPOUNDER	Outsourcing facility compounded drug report	2025-1	compounder / compounders_ndc_directory.zip	`af8e9b524e63…`	`ca326a94a5e9…`

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
BSO	119163126	70168-8300	70168-8300-1	Prasterone; Testosterone Cypionate	10 mg/1 mL; 200 mg/1 mL	2025-2	valid
BSO	119163126	70168-8300	70168-8300-1	Prasterone; Testosterone Cypionate	10 mg/1 mL; 200 mg/1 mL	2025-1	valid
BSO LLC		70168-8300	70168-8300-1	Testosterone Cypionate/DHEA	10 mg/1 mL; 200 mg/1 mL	2025-1	valid